Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Status:
Completed
Trial end date:
2020-12-18
Target enrollment:
Participant gender:
Summary
This clinical trial will evaluate the efficacy and safety of chiauranib added to chemotherapy
in patients with relapsed or refractory ovarian cancer, in the meantime, explore the
pharmacokinetics characteristic after the combined treatment.